ADC Therapeutics SA, of Lausanne, Switzerland, appointed Victor Sandor to its board.
Anika Therapeutics Inc., of Bedford, Mass., appointed Cheryl R. Blanchard president and CEO.
Arcutis Biotherapeutics Inc., of Westlake Village, Calif., appointed Halley E. Gilbert to its board, effective May 1, 2020.
Cerecor Inc., of Rockville, Md., appointed Sol J. Barer chairman of its board. Suzanne Bruhn and Joseph Miller were named directors. Chris Sullivan, vice president of finance, will serve as interim chief financial officer.
Galecto Inc., of Copenhagen, appointed Jonathan Freve chief financial officer.
Mycovia Pharmaceuticals Inc., of Durham, N.C., appointed Susan McGaurn senior director of medical affairs.
Nkarta Therapeutics Inc., of South San Francisco, appointed Laura K. Shawver and Leone Patterson to its board.
Saniona AB, of Ballerup, Denmark, appointed Rudolf Baumgartner chief medical officer and head of clinical development, effective May 1, 2020.
Touchlight Genetics Ltd., of Hampton, U.K., appointed Helen Horton chief research officer.
Veritas Pharma Inc., of Vancouver, British Columbia, appointed Lorne Mark Roseborough chair of its board and named Sharon Blady as director.
Xilio Therapeutics Inc., of Waltham, Mass., appointed Martin H. Huber chief medical officer.